| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/14/2009 | EP2014681A1 Novel antibodies inhibiting c-met dimerization, and uses thereof |
| 01/14/2009 | EP2014679A1 KDR peptides and vaccines comprising the same |
| 01/14/2009 | EP2014678A2 KDR peptides and vaccines comprising the same |
| 01/14/2009 | EP2014677A1 A-33 related antigens and their pharmacological uses |
| 01/14/2009 | EP2014670A2 Production of Glucosinolates from Agricultural By-Products and Waste |
| 01/14/2009 | EP2014663A1 Thieno-pyrimidyl amines as modulators of EP2 receptors |
| 01/14/2009 | EP2014651A1 Compounds and methods for modulating Rho GTPases |
| 01/14/2009 | EP2014303A2 APO-2L receptor agonist and CPT-11 synergism |
| 01/14/2009 | EP2014302A1 An antibody specific for the Tn antigen for the treatment of cancer |
| 01/14/2009 | EP2014300A1 Cancer vaccine comprising a cancer antigen based on the product of a tumor suppressor gene WT1 and a cationic liposome |
| 01/14/2009 | EP2014291A2 Piperazinone compounds as anti-tumor and anti-cancer agents and methods of treatment |
| 01/14/2009 | EP2014286A2 Cremophor free epothilone particles coated with protein for treating cancer |
| 01/14/2009 | EP2014283A1 Anti-inflammatory agent and cancer-preventive agent comprising canolol or prodrug thereof and pharmaceutical, cosmetic and food comprising the same |
| 01/14/2009 | EP2013228A1 Methods of inducing apoptosis of cancerous cells using apoptin derivatives |
| 01/14/2009 | EP2013207A1 Imidazo[4, 5-b]pyridin-2-one and oxazolo[4, 5-b]pyridin-2-one compounds and analogs thereof as cancer therapeutic compounds |
| 01/14/2009 | EP2013206A1 Pharmaceutical compounds |
| 01/14/2009 | EP2013198A2 Solid-state form of amg 706 and pharmaceutical compositions thereof |
| 01/14/2009 | EP2013196A2 Disubstituted aniline compounds |
| 01/14/2009 | EP2013187A2 Diarylthiohydantoin compounds |
| 01/14/2009 | EP2013186A1 Imidazole derivatives for use as edg-1 antagonists |
| 01/14/2009 | EP2013184A1 Sulfonamide compounds useful as edg receptor modulators |
| 01/14/2009 | EP2013180A1 Novel heteroaryl-substituted arylaminopyridine derivatives as mek inhibitors |
| 01/14/2009 | EP2013016A2 Liposomal nanoparticles and other formulations of fenretinide for use in therapy and drug delivery |
| 01/14/2009 | EP2012804A1 Polymer-based anti-cancer agents |
| 01/14/2009 | EP2012801A2 Gemcitabine combination therapy |
| 01/14/2009 | EP2012798A2 Use of inositol-tripyrophosphate in treating tumors and diseases |
| 01/14/2009 | EP2012791A2 7,9-dihydro-purin-8-one and related analogs as hsp90-inhibitors |
| 01/14/2009 | EP2012787A2 Combinations comprising bcr-abl/c-kit/pdgf-r tk inhibitors for treating cancer |
| 01/14/2009 | EP2012772A1 Reducing cancer cell invasion using an inhibitor of toll like receptor signaling |
| 01/14/2009 | EP2012758A2 Inhibitors of the task-1 and task-3 ion channel |
| 01/14/2009 | EP1898917B1 Aminopyrimidines as kinase modulators |
| 01/14/2009 | EP1622894B1 Antitumoral antiandrogenic pyrrolidines |
| 01/14/2009 | EP1609858B1 Method for detecting substrates or inhibitors for branched neutral amino acid transporters |
| 01/14/2009 | EP1549741B1 Novel endothelial cells, antibodies against said cells and use thereof |
| 01/14/2009 | EP1516620B1 Rifampicin for treating angiogenesis |
| 01/14/2009 | EP1497309B1 Aminoalkyl sterol compounds having an anti-tumoral and neuroprotective activity |
| 01/14/2009 | EP1466900B1 2-substituted vitamin d derivatives |
| 01/14/2009 | EP1463728B1 Fused cyclic modulators of nuclear hormone receptor function |
| 01/14/2009 | EP1456386B1 Polycistronic expression of antibodies in cho cells |
| 01/14/2009 | EP1438058B1 Aqueous extract of ceratonia siliqua leaves and pods containing polyphenols with antioxidant and antitumor activities |
| 01/14/2009 | EP1436291B1 Indolizines as kinase protein inhibitors |
| 01/14/2009 | EP1430025B1 Methods and compositions for treating or preventing bacterial infection |
| 01/14/2009 | EP1390389B1 Cripto blocking antibodies and uses thereof |
| 01/14/2009 | EP1345899B1 N-substituted amides as NK1 receptor antagonists |
| 01/14/2009 | EP1317443B1 Chemokine receptor binding heterocyclic compounds |
| 01/14/2009 | EP1311241B1 Use of a porous carrier |
| 01/14/2009 | EP1283057B1 Cell proliferation inhibitors |
| 01/14/2009 | EP1258484B1 Novel isoxazole and thiazole compounds and use thereof as drugs |
| 01/14/2009 | EP1233948B1 Stable polymorph of n-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof |
| 01/14/2009 | EP1223978B1 Archaeosomes as adjuvants and carriers for acellular vaccines to induce cytotoxic t lymphocyte (ctl) responses |
| 01/14/2009 | EP1199996A4 Real-time monitoring of photodynamic therapy over an extended time |
| 01/14/2009 | EP1187918B2 Tek antagonists |
| 01/14/2009 | EP1183049B1 Modification of biological elements |
| 01/14/2009 | EP1131337B1 Novel betulinic acid derivatives, processes for preparing such derivatives and its use as cancer growth inhibitors |
| 01/14/2009 | EP1115877B1 Polynucleotide constructs and uses thereof |
| 01/14/2009 | EP1087768B1 Use of 1-(aminoalkyl)-3-quinoxaline-2-one derivatives for the preparation of compounds having an antioxidant action |
| 01/14/2009 | EP1051189B2 Vaccine formulation containing a polycation as an adjuvant and sugar-alcohols and low concentrations of anorganic ions |
| 01/14/2009 | EP0724594B1 Regulation of transcription factor, nf-il6/lap |
| 01/14/2009 | CN101346395A Anti-IL-6 antibodies preventing the binding of IL-6 complexed with il-6Ralpha to GP130 |
| 01/14/2009 | CN101346383A 三唑衍生物 Triazole derivatives |
| 01/14/2009 | CN101346382A Carbonylamino pyrrolopyrazoles, potent kinase inhibitors |
| 01/14/2009 | CN101346380A Pyrimidine derivatives for the treatment of abnormal cell growth |
| 01/14/2009 | CN101346371A 4- (3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer |
| 01/14/2009 | CN101346361A Chemical compounds |
| 01/14/2009 | CN101346356A Aminopyrimidine derivatives inhibiting protein kinase activity, method for the preparation thereof and pharmaceutical composition containing same |
| 01/14/2009 | CN101346354A 21-deoxymacbecin analogues useful as antitumor agents |
| 01/14/2009 | CN101346149A Ultrasonic cancer treatment enhancer and cell killer |
| 01/14/2009 | CN101346146A Compounds having cytokine modulating properties |
| 01/14/2009 | CN101346142A Combination of AZD2171 and pemetrexed |
| 01/14/2009 | CN101346137A Combination comprising combretastatin and anticancer agents |
| 01/14/2009 | CN101343652A Mushroom ferment crude protein with antineoplastic activity, extracting method and formulation |
| 01/14/2009 | CN101343623A Hybrid tumor, antihuman bladder cancer monoantibody and guide medicament, and bladder cancer diagnosis agent |
| 01/14/2009 | CN101343615A Novel species of acrocarpospora, a method of preparing iodinin, and the uses of iodinin |
| 01/14/2009 | CN101343421A Preparation method for pH controlled releasedynamic polymer packaging system |
| 01/14/2009 | CN101343369A Dialdehyde starch crosslinked chitosan magnetic microsphere and preparation thereof |
| 01/14/2009 | CN101343332A Method for extracting holothurian polyoses with holothurian processing waste liquor |
| 01/14/2009 | CN101343331A Synthesis of substituted pachyman |
| 01/14/2009 | CN101343330A Preparation method for panax ginseng polyoses extract |
| 01/14/2009 | CN101343328A Target-specificity dual-mutant amalgamation protein |
| 01/14/2009 | CN101343324A Method for the inhibition of human TNF alpha activity |
| 01/14/2009 | CN101343291A Novel method for preparing oxaliplatin |
| 01/14/2009 | CN101343276A Camptothecin derivative and its preparation |
| 01/14/2009 | CN101343274A Carbazoles alkaloid, preparation and application thereof |
| 01/14/2009 | CN101343268A Thiazole couplet pyrazolone series compound and application of the same as Bcl-2 family protein antagonist |
| 01/14/2009 | CN101343265A Medicament containing cave flower active principle and formulation thereof |
| 01/14/2009 | CN101343247A Cyclohexenone extract of Antrodia camphorata |
| 01/14/2009 | CN101342360A Chinese medicinal composition for treating esophagus cancer and preparation method thereof |
| 01/14/2009 | CN101342357A Chinese medicinal composition for treating gland hyperplasia and preventing and controlling mammary cancer |
| 01/14/2009 | CN101342298A Vegetable enzyme soup formulation |
| 01/14/2009 | CN101342272A Pure natural medicament with multi-function for treating cancer |
| 01/14/2009 | CN101342271A Traditional Chinese medicine for treating qi-blood deficiency caused by tumour chemotherapy and preparation method thereof |
| 01/14/2009 | CN101342203A Anti-cancer medicine compound lychee formulation and preparation method thereof |
| 01/14/2009 | CN101342202A Application of sugar apple lactone compound V in preparing cancer-treating and anti-cancer medicine |
| 01/14/2009 | CN101342201A Application of largerstroemia subcostata extract in preparing antineoplastic medicament |
| 01/14/2009 | CN101342194A Traditional Chinese medicine preparation for treating median or late-stage malignant tumors, chronic hepatitis B, and preparation method thereof |
| 01/14/2009 | CN101342185A Application of Forsythoside A in preparing antineoplastic chemotherapy sensitivity-enhancing toxicity-reducing medicament or anti-AIDS sensitivity-enhancing toxicity-reducing medicament |
| 01/14/2009 | CN101342179A Antineoplastic traditional Chinese medicine preparation and preparation method thereof |
| 01/14/2009 | CN101342175A Application of sildenafil in preparing antineoplastic medicament |
| 01/14/2009 | CN101342158A Application of two bromine phenolic compounds in preparing medicament for treating malignant tumor |
| 01/14/2009 | CN101342157A Application of ocean bromine phenolic compound in preparing medicament for treating malignant tumor |